Business

Mah Sing gets clearance to sell medical gloves in US

Property developer’s subsidiary receives premarket notification clearances from US FDA

Updated 4 years ago · Published on 06 Dec 2021 6:00PM

Mah Sing gets clearance to sell medical gloves in US
Mah Sing, whose glove arm began operations in May, is also looking to export to Canada and Europe. – Mah Sing Healthcare pic, December 6, 2021

KUALA LUMPUR – Mah Sing Group Bhd’s healthcare unit, Mah Sing Healthcare Sdn Bhd, is poised to market medical-grade examination gloves in the United States after obtaining premarket notification clearances from the US Food and Drug Administration (FDA).

The property developer, which diversified into glove manufacturing this year, said its subsidiary had received the US FDA’s notification letter dated December 4, 2021, on the 510(k) premarket notification clearances to market nitrile examination gloves.

“This shall be updated on the FDA website in due course,” the company said in a filing with Bursa Malaysia today.

Mah Sing’s glove division began operations in May 2021. In June, the company announced it was ready for export to Europe after getting PC Management System Pvt Ltd’s Conformitè Europëenne (CE) marking certification and TUV Rheinland LGA Products GmbH’s certification for its nitrile and latex examination gloves.

“With these 510(k) clearances, a recent issuance of a medical device licence from Health Canada and pending the completion of EU Medical Device Regulation (MDR) certificate, Mah Sing Healthcare will be able to export medical-grade gloves to a wider range of markets, including major markets such as the US, Canada and Europe,” it said.

Mah Sing said that this month, it was expected to complete commissioning all 12 production lines under the first phase of its glove business.

“These new high-speed glove dipping machines can produce 38,000 pieces of gloves per production line per hour, enabling a maximum production capacity of up to 3.68 million pieces of gloves per annum,” it said.

Mah Sing Healthcare’s glove factory is a highly automated plant designed to enhance cost-effectiveness. It is equipped with auto-strip, auto-count and auto-stack features as well as auto-dosing of solutions for higher efficiency.

Mah Sing said it also has plans for auto-boxing in the near future by collaborating with packing automation specialists.

The company said its management was determined to put in place enhanced manufacturing practices and would adhere strictly to the environment, social and governance (ESG) and other international regulations such as the International Labour Organisation’s protocols.

“Demand for gloves is expected to remain steady due to structural increase in demand, fears of reinfection, increased health awareness and hygiene compliance requirements for both the healthcare and non-healthcare sectors,” it added. – Bernama, December 6, 2021

Related News

Malaysia / 4y

UK court to hear suit against govt for using gloves from M’sian firm

Business / 4y

Glove makers should switch focus to non-medical industries: Zuraida

Malaysia / 4y

Go big on high-tech manufacturing to grow economy: Dr Mahathir

World / 4y

WHO sounds medical waste alarm following Covid-19

Business / 4y

Mah Sing shares up on RM2.4 bil worth of properties’ launch in 2022

Business / 4y

Supermax rolls out new migrant worker management policy

Spotlight

Malaysia

JPJ temporarily suspends VTA and registration for Chery Omoda 5

Malaysia

Eligibility for PTPTN repayment deferment to be verified with LHDN

Malaysia

Budget allocates two rounds of cash aid to millions of Malaysians in 70th Merdeka year

Malaysia

No Malaysians killed or injured in Riyadh airport attack, says Wisma Putra

Malaysia

JAIS probes viral religious ritual footage, says AI manipulation not ruled out

Malaysia

10-tonne truck ploughs into 11 vehicles: Police probe possible brake failure

World

Trump weighs joining Saudi strikes after deadly Houthi attack on Riyadh airport

You may be interested

Business

Oil prices retreat below US$104 as markets weigh Middle East risks